Who are Mucolox® alone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): N-acetylcystein, N-acetylcysteine, N-Acetyl Cysteine (NAC), Ambroxol Hydrochloride, Acetylcysteine (NAC), Hypertonic saline and epinephrine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/mucolox-alone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Mucolox® alone — Competitive Intelligence Brief

Mucolox® alone (Mucolox® alone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mucolytic agent. Area: Respiratory.

marketed Mucolytic agent Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Mucolox® alone (Mucolox® alone) — University of Alberta. Mucolox is a mucus-thinning agent that reduces mucus viscosity to improve clearance and airway function in patients with excessive or thick mucus production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Mucolox® alone TARGET	Mucolox® alone	University of Alberta	marketed	Mucolytic agent
N-acetylcystein	N-acetylcystein	Assistance Publique - Hôpitaux de Paris	marketed	Antioxidant; mucolytic agent	Glutathione synthesis pathway; free radicals; mucus proteins
N-acetylcysteine	N-acetylcysteine	University of Turin, Italy	marketed	Antioxidant, mucolytic agent	Glutathione synthesis pathway; reactive oxygen species
N-Acetyl Cysteine (NAC)	N-Acetyl Cysteine (NAC)	The Aurum Institute NPC	marketed	Antioxidant / Mucolytic agent	Glutathione synthesis pathway; reactive oxygen species (non-specific)
Ambroxol Hydrochloride	Ambroxol Hydrochloride	National University of Malaysia	marketed	Mucolytic agent
Acetylcysteine (NAC)	Acetylcysteine (NAC)	Clinica Universidad de Navarra, Universidad de Navarra	marketed	Mucolytic agent; antioxidant	Glutathione synthesis; disulfide bonds in mucoproteins
Hypertonic saline and epinephrine	Hypertonic saline and epinephrine	Le Bonheur Children's Hospital	marketed	Combination bronchodilator and mucolytic agent	Alpha-1 adrenergic receptors, beta-2 adrenergic receptors, osmotic gradient modulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mucolytic agent class)

GlaxoSmithKline · 1 drug in this class
National University of Malaysia · 1 drug in this class
Sanofi · 1 drug in this class
University College, London · 1 drug in this class
University of Alberta · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mucolox® alone — Competitive Intelligence Brief. https://druglandscape.com/ci/mucolox-alone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab